Newsroom

Jan 5, 2026 Team Zepto Life Technology Welcomes Dr. David S. Perlin to our Advisory Board The globally recognized biomedical scientist and Journal of Fungi Editor-in-Chief joins Zepto's Medical & Technical Advisory Board. → Mar 16, 2025 Investors Zepto Life Technology Showcases Transformative Diagnostic Platform at LSI USA 2025 Zepto presents its GMR biosensor platform to investors and industry leaders shaping the future of healthcare. → Feb 25, 2025 FungiFlex Zepto Publishes Breakthrough Culture-Free Diagnostic Approach for Invasive Fungal Infections in Open Forum Infectious Diseases The study introduces a rapid molecular platform for detecting fungal cell-free DNA, offering an alternative to conventional culture-based diagnosis. → Jan 17, 2025 Investors Walleye Tank Pitch Contest Awards Zepto with Top Prize for Innovative Fungal Diagnostic Platform Hosted by Mayo Clinic and the University of Minnesota, the win recognizes Zepto's GMR-based diagnostic system. → Jan 14, 2025 Investors Zepto Life Technology Presents at J.P. Morgan 2025 Healthcare Conference and Engages with Global Leaders in Medical Innovation Zepto engages with global investors and strategic partners on faster, more accurate infectious disease diagnostics. → Jun 14, 2024 FungiFlex Zepto Life Technology’s New Publication: cfDNA and GMR Technology in the Journal of Fungi A University of Minnesota collaboration explores GMR-based cfDNA detection for monitoring fungal infection response to therapy. →